Mass. DA's Probe Into Boston Scientific Corporation's CRM Unit is Over

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Boston Scientific says a probe by the U.S. District Attorney for Massachusetts into its cardiac rhythm management unit is over. A probe by the U.S. District Attorney for Massachusetts into Boston Scientific's (NYSE:BSX) cardiac rhythm management unit has been put to bed, the medical device company said yesterday. The Bay State DA's office sent a subpoena to Natick, Mass.-based Boston Scientific in March 2010, "relating to the former Market Development Sales Organization that operated within our CRM business," according to a regulatory filing.

Help employers find you! Check out all the jobs and post your resume.

Back to news